| Announce Date | 11/20/2025 |
| EPS Normalized Actual | $2.07 (Miss by $-0.01) |
| EPS GAAP Actual | $2.07 (Miss by $-0.01) |
| Revenue Actual | $28.3586B |
| Revenue Surprise | Beat by $28358.6M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $15.83634 |
| EPS GAAP Estimate | $15.83634 |
| Revenue Estimate | $4.577461301B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 74.01937 | 1.6 | 66.44798 | 81.30202 | 3 |
| Dec 2027 | 65.77655 | 1.8 | 63.05503 | 71.67025 | 5 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 13.5 | -1.59962 | 28.3586B | 7.58% | 23901.35M |
| FQ2 2025 (Jun 2025) | 13.5 | -1.74791 | 27.8917B | 8.63% | 23236.93M |
| FQ1 2025 (Mar 2025) | 16.25 | -0.6479 | 28.8285B | 6.86% | 23948.53M |
| FQ4 2024 (Dec 2024) | 2.73 | -10.0704 | 26.7478B | -1.47% | 22527.06M |
| FQ3 2024 (Sep 2024) | 0 | -1.53737 | 26.2099B | -4.05% | -27815.53M |
| FQ2 2024 (Jun 2024) | 0 | 0 | 25.4858B | 5.79% | 25485.8M |
| FQ1 2024 (Mar 2024) | 11.9 | 11.9 | 26.8517B | 6.72% | 26851.7M |
| FQ4 2023 (Dec 2023) | 10.1 | 10.1 | 27.1402B | 6.58% | 27140.2M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
15.83634
Consensus Revenue Estimates
4.577461301B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 17.86424 | -- | 17.00585 | 18.9519 | 1 |
| FQ3 2027 (Sep 2027) | 15.68623 | -- | 14.81791 | 16.95092 | 1 |
| FQ2 2027 (Jun 2027) | 15.84939 | -- | 14.97204 | 17.12723 | 1 |
| FQ1 2027 (Mar 2027) | 18.06783 | -- | 17.19965 | 19.16788 | 1 |
| FQ4 2026 (Dec 2026) | 10.1589 | -- | 9.86068 | 10.40944 | 1 |
| FQ3 2026 (Sep 2026) | 14.4689 | 6.7 | 14.04416 | 14.82573 | 1 |
| FQ2 2026 (Jun 2026) | 14.33589 | 5.83 | 13.91505 | 14.68944 | 1 |
| FQ1 2026 (Mar 2026) | 15.83634 | -2.61 | 15.37145 | 16.2269 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 39.31B | -- | 37.85B | 41.15B | 3 |
| FQ3 2027 (Sep 2027) | 33.54B | -- | 32.11B | 35.62B | 3 |
| FQ2 2027 (Jun 2027) | 33.18B | -- | 31.76B | 35.23B | 3 |
| FQ1 2027 (Mar 2027) | 33.93B | -- | 32.67B | 35.52B | 3 |
| FQ4 2026 (Dec 2026) | 3.29B | -- | 3.21B | 3.35B | 2 |
| FQ3 2026 (Sep 2026) | 4.27B | -563.42 | 4.18B | 4.36B | 2 |
| FQ2 2026 (Jun 2026) | 4.38B | -536.64 | 4.28B | 4.46B | 2 |
| FQ1 2026 (Mar 2026) | 4.58B | -529.79 | 4.47B | 4.66B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
2
EPS # of Misses
5
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 15.09962 | 13.5 | -1.59962 | -11.85% |
| FQ2 2025 (Jun 2025) | 15.24791 | 13.5 | -1.74791 | -12.95% |
| FQ1 2025 (Mar 2025) | 16.8979 | 16.25 | -0.6479 | -3.99% |
| FQ4 2024 (Dec 2024) | 12.8004 | 2.73 | -10.0704 | -368.88% |
| FQ3 2024 (Sep 2024) | 1.53737 | 0 | -1.53737 | -INF% |
| FQ2 2024 (Jun 2024) | 0 | 0 | NAN% | |
| FQ1 2024 (Mar 2024) | 11.9 | 11.9 | 100% | |
| FQ4 2023 (Dec 2023) | 10.1 | 10.1 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $4.46B | $28.36B | $23901.35M | 84.28% |
| FQ2 2025 (Jun 2025) | $4.65B | $27.89B | $23236.93M | 83.31% |
| FQ1 2025 (Mar 2025) | $4.88B | $28.83B | $23948.53M | 83.07% |
| FQ4 2024 (Dec 2024) | $4.22B | $26.75B | $22527.06M | 84.22% |
| FQ3 2024 (Sep 2024) | $54.03B | $26.21B | $-27815.53M | -106.13% |
| FQ2 2024 (Jun 2024) | $0B | $25.49B | $25485.8M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $26.85B | $26851.7M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $27.14B | $27140.2M | 100% |